Media-OutReach Newswire The United Laboratories International Holdings Limited Applies for the Clinical Trial of its Class 1 Innovative New Drug UBT251 Injection
Media-OutReach Newswire Yeebo Announces Annual Results for FY2022/23; Profit Attributable to Owners Surged by 131%
Media-OutReach Newswire Kenanga Investment Bank Celebrates 50 Years of Growth, Innovation, and Excellence
Media-OutReach Newswire Jollibee Foods Corporation starts the year strong, Reports +20.2% Systemwide Sales Growth in North America in Q1 2023